Khateb, Ali
Deshpande, Anagha
Feng, Yongmei
Finlay, Darren http://orcid.org/0000-0002-8718-9453
Lee, Joo Sang http://orcid.org/0000-0001-8564-0848
Lazar, Ikrame
Fabre, Bertrand
Li, Yan
Fujita, Yu http://orcid.org/0000-0002-8916-7303
Zhang, Tongwu http://orcid.org/0000-0003-2124-2706
Yin, Jun
Pass, Ian
Livneh, Ido
Jeremias, Irmela http://orcid.org/0000-0003-1773-7677
Burian, Carol
Mason, James R.
Almog, Ronit
Horesh, Nurit
Ofran, Yishai
Brown, Kevin http://orcid.org/0000-0002-8558-6711
Vuori, Kristiina http://orcid.org/0000-0002-5657-0681
Jackson, Michael
Ruppin, Eytan
Deshpande, Aniruddha J. http://orcid.org/0000-0002-5240-9356
Ronai, Ze’ev A. http://orcid.org/0000-0002-3859-0400
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (R35CA197465)
Article History
Received: 23 May 2021
Accepted: 18 August 2021
First Online: 13 September 2021
Competing interests
: ZAR is co-founder and serves as scientific advisor to Pangea Therapeutics. All other authors declare no competing interests.